These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 28800947)

  • 41. [Large-vessel vasculitis-giant cell and Takayasu arteritis].
    Villiger PM
    Internist (Berl); 2019 Oct; 60(10):1059-1073. PubMed ID: 31471629
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A severe cerebral infarction associated with giant cell arteritis, which developed during tocilizumab therapy and was successfully treated with intravenous cyclophosphamide.
    Suzuki K; Akiyama M; Ishigaki S; Kondo Y; Saito S; Kikuchi J; Hanaoka H; Kaneko Y
    Mod Rheumatol Case Rep; 2023 Jun; 7(2):453-457. PubMed ID: 36715093
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Giant cell arteritis: what is new in the preclinical and early clinical development pipeline?
    Harkins P; Conway R
    Expert Opin Investig Drugs; 2022 Sep; 31(9):921-932. PubMed ID: 34106030
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tocilizumab monotherapy for large vessel vasculitis: results of 104-week treatment of a prospective, single-centre, open study.
    Saito S; Okuyama A; Okada Y; Shibata A; Sakai R; Kurasawa T; Kondo T; Takei H; Amano K
    Rheumatology (Oxford); 2020 Jul; 59(7):1617-1621. PubMed ID: 31665468
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pathogenesis of giant cell arteritis: More than just an inflammatory condition?
    Ly KH; Régent A; Tamby MC; Mouthon L
    Autoimmun Rev; 2010 Aug; 9(10):635-45. PubMed ID: 20457278
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is statin exposure associated with occurrence or better outcome in giant cell arteritis? Results from a French population-based study.
    Pugnet G; Sailler L; Bourrel R; Montastruc JL; Lapeyre-Mestre M
    J Rheumatol; 2015 Feb; 42(2):316-22. PubMed ID: 25512477
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Treatment of Giant Cell Arteritis in Different Clinical Settings.
    Pfeil A; Oelzner P; Hellmann P
    Front Immunol; 2018; 9():3129. PubMed ID: 30733723
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Treatment of giant cell arteritis: what is in the pipeline?].
    Holle JU; Moosig F
    Z Rheumatol; 2020 Aug; 79(6):516-522. PubMed ID: 32399619
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recent advances in the treatment of giant cell arteritis.
    Springer JM; Kermani TA
    Best Pract Res Clin Rheumatol; 2023 Mar; 37(1):101830. PubMed ID: 37328409
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
    Unizony S; Arias-Urdaneta L; Miloslavsky E; Arvikar S; Khosroshahi A; Keroack B; Stone JR; Stone JH
    Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1720-9. PubMed ID: 22674883
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tocilizumab in Giant Cell Arteritis: A Real-Life Retrospective Study.
    Vitiello G; Orsi Battaglini C; Carli G; Radice A; Matucci A; Vultaggio A; Olianti C; Parronchi P; Maggi E; Cammelli D
    Angiology; 2018 Oct; 69(9):763-769. PubMed ID: 29343075
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel aspects of regulatory T cell dysfunction as a therapeutic target in giant cell arteritis.
    Adriawan IR; Atschekzei F; Dittrich-Breiholz O; Garantziotis P; Hirsch S; Risser LM; Kosanke M; Schmidt RE; Witte T; Sogkas G
    Ann Rheum Dis; 2022 Jan; 81(1):124-131. PubMed ID: 34583923
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice.
    Calderón-Goercke M; Loricera J; Aldasoro V; Castañeda S; Villa I; Humbría A; Moriano C; Romero-Yuste S; Narváez J; Gómez-Arango C; Pérez-Pampín E; Melero R; Becerra-Fernández E; Revenga M; Álvarez-Rivas N; Galisteo C; Sivera F; Olivé-Marqués A; Álvarez Del Buergo M; Marena-Rojas L; Fernández-López C; Navarro F; Raya E; Galindez-Agirregoikoa E; Arca B; Solans-Laqué R; Conesa A; Hidalgo C; Vázquez C; Román-Ivorra JA; Lluch P; Manrique-Arija S; Vela P; De Miguel E; Torres-Martín C; Nieto JC; Ordas-Calvo C; Salgado-Pérez E; Luna-Gomez C; Toyos-Sáenz de Miera FJ; Fernández-Llanio N; García A; Larena C; Palmou-Fontana N; Calvo-Río V; Prieto-Peña D; González-Vela C; Corrales A; Varela-García M; Aurrecoechea E; Dos Santos R; García-Manzanares Á; Ortego N; Fernández S; Ortiz-Sanjuán F; Corteguera M; Hernández JL; González-Gay MÁ; Blanco R
    Semin Arthritis Rheum; 2019 Aug; 49(1):126-135. PubMed ID: 30655091
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparing treatment options for large vessel vasculitis.
    Macaluso F; Marvisi C; Castrignanò P; Pipitone N; Salvarani C
    Expert Rev Clin Immunol; 2022 Aug; 18(8):793-805. PubMed ID: 35714219
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Advances in the Treatment of Giant Cell Arteritis.
    Castañeda S; Prieto-Peña D; Vicente-Rabaneda EF; Triguero-Martínez A; Roy-Vallejo E; Atienza-Mateo B; Blanco R; González-Gay MA
    J Clin Med; 2022 Mar; 11(6):. PubMed ID: 35329914
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial.
    Mazlumzadeh M; Hunder GG; Easley KA; Calamia KT; Matteson EL; Griffing WL; Younge BR; Weyand CM; Goronzy JJ
    Arthritis Rheum; 2006 Oct; 54(10):3310-8. PubMed ID: 17009270
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tocilizumab as an add-on therapy to glucocorticoids during the first 3 months of treatment of Giant cell arteritis: A prospective study.
    Samson M; Devilliers H; Ly KH; Maurier F; Bienvenu B; Terrier B; Charles P; Guillevin L; Besancenot JF; Liozon E; Fauchais AL; Loffroy R; Binquet C; Audia S; Seror R; Mariette X; Bonnotte B
    Eur J Intern Med; 2018 Nov; 57():96-104. PubMed ID: 30054122
    [TBL] [Abstract][Full Text] [Related]  

  • 58. European Headache Federation recommendations for neurologists managing giant cell arteritis.
    Mollan SP; Paemeleire K; Versijpt J; Luqmani R; Sinclair AJ
    J Headache Pain; 2020 Mar; 21(1):28. PubMed ID: 32183689
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reducing the Toxicity of Long-Term Glucocorticoid Treatment in Large Vessel Vasculitis.
    Palmowski A; Buttgereit F
    Curr Rheumatol Rep; 2020 Oct; 22(12):85. PubMed ID: 33047263
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is there a place for cyclophosphamide in the treatment of giant-cell arteritis? A case series and systematic review.
    de Boysson H; Boutemy J; Creveuil C; Ollivier Y; Letellier P; Pagnoux C; Bienvenu B
    Semin Arthritis Rheum; 2013 Aug; 43(1):105-12. PubMed ID: 23453684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.